Reinventing oxygen concentration & removal. Our novel, patent-pending process generates higher purity O2 at 4x the flow rate of existing PSA oxygen concentrator technology

We are developing oxygen concentration and removal products in several industries.

In the field of medicine, our portable, consumer units will provide greater freedom and independence to patients requiring higher O2 flow (up to 6 L/min) than existing portable oxygen concentrators can provide (up to 1.5 L/min)

Our medical & industrial oxygen equipment will mitigate O2 shortages and supply chain disruptions - issues that have been exacerbated during the Covid-19 pandemic.

Health Care

Industrial

Medical Devices

AirOmatix Inc

AirOmatix Inc's headquarters in Portland, United States

Description

People (2)

Theresa McCormick

Jun Kamata

Jobs